top of page

Yesintek Concentrate for solution for infusion 130mg/26mL

Product details

Registration number: SIN17571P

Classification: Prescription Only

Active ingredients: Ustekinumab

Strength: 130mg/26mL

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: CEDAR PHARMACEUTICALS PTE. LTD.

ATC code: L04AC05

HSA approval date: 26 June 2026

Manufacturer(s): Biocon Biologics Limited

Manufacturing country/countries: INDIA

What are the HSA registration number and classification for Yesintek Concentrate for solution for infusion 130mg/26mL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17571P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Yesintek Concentrate for solution for infusion 130mg/26mL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Ustekinumab

Strength: 130mg/26mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Yesintek Concentrate for solution for infusion 130mg/26mL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for Yesintek Concentrate for solution for infusion 130mg/26mL?

According to the HSA dataset updated 7 August 2026:

Registrant: CEDAR PHARMACEUTICALS PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Yesintek Concentrate for solution for infusion 130mg/26mL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Biocon Biologics Limited

Manufacturing country/countries: INDIA

Source for this answer

Where can I look up Yesintek Concentrate for solution for infusion 130mg/26mL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17571P or the exact product name Yesintek Concentrate for solution for infusion 130mg/26mL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Yesintek Concentrate for solution for infusion 130mg/26mL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Yesintek Concentrate for solution for infusion 130mg/26mL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17571P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page